Outlook Therapeutics (OTLK) Change in Taxes (2015 - 2016)
Outlook Therapeutics (OTLK) posted quarterly Change in Taxes of $50000.0 for Q1 2016, little changed quarter-over-quarter from $50000.0 in Q4 2015.
Outlook Therapeutics (OTLK) Change in Taxes (2015 - 2016) Analysis & Trends
Outlook Therapeutics (OTLK) has reported Change in Taxes for 2 consecutive years, with $50000.0 the latest figure, recorded in Q1 2016.
- In Q1 2016, Change in Taxes changed N/A year-over-year to $50000.0; the TTM figure through Sep 2016 stood at $100000.0 (changed N/A YoY), while the FY2025 annual figure was -$1.6 million, changed N/A from the prior year.
- Change in Taxes held at $50000.0 in Q1 2016 per OTLK's latest filing, from $50000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $50000.0 in Q4 2015 and bottomed at $9745.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 50,000.00 |
| Mar 31, 2016 | 50,000.00 |
| Dec 31, 2015 | 50,000.00 |
| Dec 31, 2015 | 50,000.00 |
| Sep 30, 2015 | 9,745.00 |
| Sep 30, 2015 | 9,745.00 |
| Jun 30, 2015 | 29,360.00 |
| Jun 30, 2015 | 29,360.00 |